SOGROYA sol inj 10 mg/1.5ml stylo pré 1.5 ml
7680690630027
CH-69063
H01AC07
07.03.1.
Reimbursement limitations:
SOGROYA.01
SOGROYA est remboursé pour la substitution de l'hormone de croissance endogène (Growth Hormone, GH) chez …
1 / 3
google
Details
- Product number
- 6906302
- CPT
- -
- Packaging group
- 1.5
- Unit
- ml
- Composition
- somapacitanum 10 mg, histidinum, mannitolum, poloxamerum 188, phenolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 0.075 mg.
Articles (1)
Sogroya 10 mg/ 1.5 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1.5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 652.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 69063
- Drug name
- Sogroya, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- H01AC07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/04/2024
- Authorization expiration date
- 25/04/2029
- IT number
- 07.03.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SOGROYA sol inj 10 mg/1.5ml stylo pré 1.5 ml
- Description (DE)
- SOGROYA Inj Lös 10 mg/1.5ml Fertpen 1.5 ml
- Market launch
- 26/04/2024
- Narcotic (BTM)
- No